Trihydroxyethylrutin Troxerutin-P OT15980 OT-15980 CAS: 7085-55-4

CAS NO: 7085-55-4
Trihydroxyethylrutin Troxerutin-P OT15980 OT-15980
Chemical Name: Troxerutin
Molecular Formula: C33H42O19
Formula Weight: 742.68
CAS No.: 7085-55-4
Description Review
Description

Trihydroxyethylrutin, also known as troxerutin, is a flavonoid that is commonly used as a dietary supplement due to its potential health benefits. The chemical name for this compound is 3',4',5,7-tetrahydroxyflavanone-3-[(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside)-2-(3,4-dihydroxyphenyl)ethyl] ether. Its molecular formula is C33H42O19, and its formula weight is 742.67 g/mol. Trihydroxyethylrutin has a CAS number of 7085-55-4.

Top Ten Keywords from Google:

  1. Troxerutin
  2. Trihydroxyethylrutin
  3. OT15980
  4. Flavonoid
  5. Antioxidant
  6. Anti-inflammatory
  7. Venous insufficiency
  8. Edema
  9. Oxidative stress
  10. Cardiovascular health

Synonyms: Troxerutin-P, OT15980, OT-15980, 3',4',5,7-Tetrahydroxyflavanone-3-[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-6-(3,4,5-trihydroxybenzyl)-d-glucopyranoside, Troxerutina, Troxerutinum.

Health Benefits of Trihydroxyethylrutin: Trihydroxyethylrutin (troxerutin) exhibits several potential health benefits including:

  1. Anti-inflammatory - Trihydroxyethylrutin has been shown to reduce inflammation by inhibiting the production of inflammatory cytokines in the body.

  2. Antioxidant properties - This flavonoid has potent antioxidant properties that help to protect cells from oxidative damage caused by free radicals.

  3. Venous insufficiency - Trihydroxyethylrutin has been used to treat venous insufficiency, a condition where blood flow in the veins is compromised leading to swelling, pain, and varicose veins.

  4. Edema - Trihydroxyethylrutin may help to reduce edema or swelling by improving microcirculation and enhancing lymphatic drainage.

  5. Cardiovascular health - Research suggests that trihydroxyethylrutin may have beneficial effects on cardiovascular health by improving endothelial function, reducing blood pressure, and lowering cholesterol levels.

Potential Effects: Trihydroxyethylrutin (troxerutin) has several potential effects on the body. It may help to reduce inflammation, protect cells from oxidative damage, improve blood flow, and promote cardiovascular health.

Product Mechanism: The exact mechanism of action of trihydroxyethylrutin is not fully understood. However, it is believed to exert its effects by modulating various signaling pathways in the body. For example, it may inhibit the production of inflammatory cytokines and enhance the activity of antioxidant enzymes. Additionally, it may improve blood flow by promoting the release of nitric oxide and enhancing the expression of vascular endothelial growth factor (VEGF), which stimulates the growth of new blood vessels.

Safety: Trihydroxyethylrutin (troxerutin) is generally considered safe when taken at recommended doses. However, some people may experience mild side effects such as nausea, diarrhea, or headache.

Side Effects: Trihydroxyethylrutin (troxerutin) may cause mild side effects such as gastrointestinal upset, headache, and dizziness. These side effects are usually mild and resolve on their own after discontinuing use.

Dosing Information: The optimal dosage of trihydroxyethylrutin (troxerutin) depends on several factors such as age, weight, and medical history. As a dietary supplement, typical doses range from 300-600 mg per day.

Conclusion: Trihydroxyethylrutin (troxerutin) is a flavonoid with potent anti-inflammatory and antioxidant properties that may have several potential health benefits. It has been used to treat conditions such as venous insufficiency, edema, and cardiovascular disease. While it is generally considered safe, individuals should speak with their healthcare provider before taking any dietary supplements.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us